Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone vs Tirilazad for Acute Spinal Cord Injury
NCT00004759Phase 3Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Dec 1991
- Primary completion
- Aug 2007
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone, Tirilazad in spinal cord injury (SCI), sponsored by National Institute of Neurological Disorders and Stroke. Started Dec 1991; status: completed.
02
Drugs
methylprednisoloneTirilazad
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT00004759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004759.